Rifampicin (Rifabutin Rifampin) ๐
๐ Rifampicin is a cornerstone in TB therapy but a potent enzyme inducer.
โ ๏ธ It reduces oral contraceptive pill (OCP) effectiveness โ alternative contraception required.
๐๏ธ Can cause orange-red discolouration of urine, tears, and other secretions (warn patients - contact lenses may stain).
๐ About
- Broad-spectrum bactericidal antibiotic.
- Key drug in tuberculosis (TB) regimens.
- Also used in leprosy, meningococcal carriage eradication, and certain resistant infections.
- Check the BNF here for up-to-date prescribing.
โ๏ธ Mechanism of Action
- Binds to the ฮฒ-subunit of bacterial DNA-dependent RNA polymerase.
- Blocks RNA synthesis โ bactericidal against mycobacteria.
- Potent inducer of hepatic CYP450 enzymes โ major source of drug interactions.
- Well absorbed, widely distributed.
๐ฏ Indications
- Mycobacterial infections: TB, leprosy.
- Meningococcal prophylaxis: eradication of carriage.
- Other infections: staphylococcal endocarditis (with other agents), Legionnaireโs disease, brucellosis, some cases of severe CAP.
๐ Dosing โ Pyrazinamide (check BNF/local policy)
| Indication |
Dose & Notes |
| ๐ Tuberculosis (part of combination therapy) |
โข Typical adult dose: 10 mg/kg once daily (max 600 mg/day)
โข Some regimens: 600 mg BD PO/IV (specialist use, severe cases)
โข Take on an empty stomach before breakfast for best absorption
โข Check renal and liver function before starting, then monitor regularly
|
โ ๏ธ Side Effects
- Hepatitis: transient โ LFTs; rare but serious hepatotoxicity (higher risk with alcohol use or pre-existing liver disease).
- Haematological: thrombocytopenia, haemolysis, rare TTP.
- Renal: interstitial nephritis, acute renal failure.
- Dermatological: StevensโJohnson syndrome (SJS), toxic epidermal necrolysis (TEN).
- Secretions: red/orange discolouration of urine, sweat, sputum, tears (harmless but alarming to patients).
โ๏ธ Cautions
- Adjust dose in severe renal/hepatic impairment.
- Monitor LFTs, FBC, U&E regularly.
- Avoid alcohol (โ hepatotoxic risk).
- Check INR closely if co-prescribed with warfarin.
- Warn patients re: contraception failure if using OCP.
โ Contraindications
- Hypersensitivity to rifamycins.
- Acute jaundice or severe hepatic impairment.
๐ Interactions
- Potent CYP450 inducer: โ plasma concentration of many drugs.
- Reduces efficacy of:
โ OCP ๐ (contraception failure risk)
โ Warfarin (โ INR)
โ DOAC (โ effectiveness so check)
โ Sulphonylureas
โ Steroids, barbiturates
โ Calcium channel blockers
โ Many HIV drugs (notably protease inhibitors & NNRTIs)
- Always check BNF for a full list before prescribing.
๐ก Clinical Pearls
- Always prescribe in combination (never monotherapy in TB - resistance develops rapidly).
- Warn patients about orange discolouration of urine, sweat, and tears.
- Monitor for hepatitis symptoms: jaundice, abdominal pain, dark urine.
- Women on OCP need reliable alternative contraception.